Important Changes in UK Law on Reproductive and Genetic Technologies
By David King,
Genetic Crossroads
| 01. 26. 2007
Editor's note:
Many consider the UK approach to human biotechnologies to be a model of comprehensive and responsible policy. Since its creation in 1990, a government agency called the Human Fertilisation and Embryology Authority (HFEA) has set and enforced regulations for assisted reproductive technology and research involving human embryos. Observers often contrast this situation to the "Wild West" in the United States, where regulation and public oversight of these technologies are minimal.
Here, Dr. David King gives his views on government proposals that would reorganize the HFEA and set important new rules. King is a former molecular biologist and director of Human Genetics Alert, an independent watchdog group based in London.
By David King, PhD
In December, the UK government published a set of proposals that would reform the Human Fertilization and Embryology Act. The legislation dates from 1990; in recent years scientific developments and changes in social attitudes have made it increasingly outdated.
The government's proposals follow a public consultation on the law in 2005, and precede publication later this year of draft legislation, which will be scrutinized...
Related Articles
By Kristine Servando, Bloomberg | 12.05.2024
(Bloomberg) — A woman in Hong Kong had to travel to two different countries to attempt conceiving a baby on her own. A gay couple in the city resorted to even bigger extremes: Banned from surrogacy, they turned to the...
By Sarojini Nadimpally and Gargi Mishra, The Wire | 12.15.2024
In-vitro fertilisation (IVF) as assisted reproductive technology (ART) has been in vogue for quite a few decades now. While IVF has been hailed as a significant scientific advancement, with many advantages, here are some limitations which bear keeping in mind...
By Natalie Obiko Pearson, Jessica Brice, Susan Berfield, Vernon Silver, Kanoko Matsuyama, Cindy Wang, Sinduja Rangarajan, Fani Nikiforaki, Bloomberg | 12.12.2024
A single cell.
A global business worth billions.
A trade that can bring rewards—or human costs that cannot be measured.
The human egg is a precious resource, exchanged in markets open, gray or black. To tell its story, we follow...
By Michelle LePage, TorontoMet Today | 12.13.2024
As more people access fertility services in their journeys to becoming parents, Toronto Metropolitan University professor Katie Hammond says the Canadian fertility industry is in need of greater oversight.
A professor at the Lincoln Alexander School of Law, Hammond’s latest...